Articles | Volume 5, issue 2
https://doi.org/10.7150/jbji.42448
© Author(s) 2020. This work is distributed under the Creative Commons Attribution 4.0 License.
Original full-length article
| 
21 Feb 2020
Original full-length article |
| 21 Feb 2020
| 21 Feb 2020
Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis
Cited articles
Cerceo E, Deitelzweig SB, Sherman BM. et al. Multidrug-resistant Gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist. 2016;22:412–31. doi: 10.1089/mdr.2015.0220.
Bassetti M, Russo A, Carnelutti A. et al. Antimicrobial resistance and treatment: an unmet clinical safety need. Expert Opin Drug Saf. 2018;17:669–80. doi: 10.1080/14740338.2018.1488962.
Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358:1271–81. doi: 10.1056/NEJMra070741.
Mody RM, Zapor M, Hartzell JD. et al. Infectious complications of damage control orthopedics in war trauma. J Trauma. 2009;67:758–61. doi: 10.1097/TA.0b013e3181af6aa6.
